AI-generated summary
This before-and-after observational study of women with interstitial cystitis/bladder pain syndrome who chose transvaginal photobiomodulation in 17 US practices found that 63.9% reported a meaningful pain reduction of at least 2 points on a 0-10 scale after 8 treatments. The authors describe these findings as promising but note that controlled studies are needed.
- Participants
- 140
- Who or what was studied
- Women with interstitial cystitis/bladder pain syndrome who self-selected transvaginal photobiomodulation therapy in 17 US practices
- Limits stated in the abstract
- The study is an uncontrolled, before-and-after observational cohort, and the authors state that controlled studies are needed.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Minimal clinically important difference, Observational study, Effect size, Primary outcome. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.